Status:
COMPLETED
People Living With HIV/AIDS, Nitrate, Endotelial Function, Arterial Stiffness and Skeletal Muscle Oxygenation
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
HIV/AIDS
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
Administration of antiretroviral therapy has brought benefits for infective human immunodeficiency virus-1 (HIV-1)-patients, reducing the number of AIDS-related morbidity and mortality. However, it is...
Eligibility Criteria
Inclusion
- HIV infection for a period of 1 year or greater
- Regular use of high-potency antiretroviral therapy for at least one year
Exclusion
- Individuals who are physically active
- Individuals who are allergic to some component of beet
- Individuals who use nutritional and / or pharmacological ergogenics
- Individuals receiving antibiotics or who have osteomioarticular problems
Key Trial Info
Start Date :
October 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2018
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03485248
Start Date
October 18 2017
End Date
November 28 2018
Last Update
April 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DST / AIDS and Viral Hepatitis Program of Macaé
Macaé, Rio de Janeiro, Brazil